Latest news
TALAPRO-3 Results and the Role of Upfront PARP Inhibition in APMS Prostate Cancer - Andrew Armstrong - UroTodayUroToday · Fri, 07 Aug 2026 19:52:20 GMTUSPCC 2026: Point-Counterpoint 3: Treatment of Metastatic APMN/S Prostate Cancer: Metastasis Directed Radiation - UroTodayUroToday · Fri, 07 Aug 2026 01:04:09 GMTCAPItello-281 and the PTEN-Deficient Subset of Metastatic Hormone-Sensitive Prostate Cancer - Alicia Morgans - UroTodayUroToday · Thu, 06 Aug 2026 17:23:13 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMT